Why Long-Term Investors Should Be Buying Stocks

Feb. 4 (Bloomberg) -- Independent Trader Ken Polcari discusses the outlook for the U.S. stock market and Federal Reserve monetary policy. He speaks with Matt Miller on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
What Makes Mylan Worth $40.1B to Teva Pharmaceuticals?
22:33 - Teva Pharmaceuticals has submitted a $40.1 billion unsolicited offer for Mylan in what would be this year’s largest takeover in the pharmaceutical industry. Bloomberg’s David Wainer and Drew Armstrong examine the bid on “Market Makers.” (Source: Bloomberg)
  • DuPont Profit Beats Ahead of Activist Proxy Showdown
  • El-Erian Says Greece, Creditors Heading Toward `Accident'
  • Google Makes Mobile a Priority in New Search Algorithm